Anthropic wants to use Claude AI to help discover new lifesaving drugs, says 'the best way to identify and work through these bottlenecks is to get deeply involved in real drug programs'

Anthropic partnered with pharmaceutical companies to use its Claude model for molecular design, documentation checks, and clinical trial planning. Researchers used the tool to shorten CAR T-cell components, propose allergy antibodies, and evaluate study protocols. These tools reduce the time needed to screen early drug candidates and assess clinical trials.

Summary written by AI Business Lens with an AI model from the article at techradar.com. It is not the article, and the publisher has not reviewed it. For publishers.

Read the original at techradar.com   Generate teaching or study materials

Instructors get discussion guides, assignments, and mini-cases. Students and readers get a plain summary, points to raise, an exercise, and a self-check. All built from the full article. A free account saves stories and gives you three generations. Stories stay on the brief for 14 days. After that this page keeps the link to the original.

More in Pharmacy

• Wearable devices + AI analysis may predict high blood pressure crisis up to 3 days earlyMedical Xpress · November 2, 2026
• Google is building NASA a robot doctor for use on future deep space missionsTechRadar · November 2, 2026
• Non-experts with AI guidance and off-site review perform quality mobile rural heart scansMedical Xpress · November 2, 2026
• MMI Raises $125M to Expand Robotic Microsurgery and Explore New TreatmentsMedCity News · November 1, 2026
• Chemists develop AI tool to convert human ingenuity into life-enhancing enzymesPhys.org — Chemistry · November 1, 2026